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IHC analysis of proliferative activity showed significant rise in Ki-67 signal in 
esiNanog and esiTrrap, as well as in 5azaC treated embryos/teratomas, compared to 
control. Apoptotic activity showed no significant change in any treatment. 
This preliminary data notifies that epigenetic drugs and agents may have a sig-
nificant effect on embryo/teratoma growth. It seems that teratoma growth is inhib-
ited by necrotic activity rather than apoptosis which could consequently induce a 
rise in proliferation as a tissue reaction. 
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mouse teratocarcinoma in vivo.
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In line with the growing interest for studying apoptosis in blood vessels, this 
study is one of the first to assess the apoptosis in native veins used for arteriovenous 
fistulas (AVF) done for hemodialysis. The aim of this study was to evaluate apoptosis 
in previously punctured native veins (study groupy) compared with not punctured 
native veins (controls) in patients who undergo a surgical procedure for AVF as dialy-
sis access. Cephalic vein specimens were obtained from 60 patients before the place-
ment of AVF. Half of the specimens were from the previously punctured and half 
from non-punctured veins. A 1-cm long segment was excised from distal part of the 
cephalic vein, divided into two portions along longitudinal axis and prepared for im-
munohistochemical analysis. Immunohistochemical assessment and quantification of 
signals was used to evaluate the expression of Bax, p53, caspase 3 and Bcl-2.
Vein specimens from the study group with previously punctured veins showed 
significantly increased caspase 3 and Bax expression, compared with the control 
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group (p<0.01). Bcl-2 expression in the study group was significantly decreased 
compared with the control group (p<0.01). p53 showed no significant differences 
between the two groups (p=0.791). There were statistically significant differences 
in fistula failure between the study group and control group (26.7% versus 6.7%, 
p=0.038). The association we have found between previously punctured veins and 
apoptosis indicates the role that venipuncture may play in the development of apop-
tosis. Patients with increased apoptosis showed an increased fistula failure, which is 
of importance for the improvement of the AVF procedure itself.
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Survivin, encoded by BIRC5 gene, belongs to the family of inhibitors of apopto-
sis (IAP) proteins. Survivin is an essential chromosomal passenger protein required 
for mitotic progression. It is also an inhibitor of apoptosis and can prevent caspase-
mediated cell death. It is usually expressed in embryonic tissues and homozygous 
survivin deletion results in early embryonic death, showing its essential role in cell 
development, differentiation and homeostasis. In healthy organisms it is not ex-
pressed in differentiated tissues, while its expression is markedly increased in most 
cancers (including bladder cancer, lung cancer, breast cancer, stomach, esophagus, 
liver, ovarian cancers and hematological cancers).
In tumors its presence correlates with increased resistance to chemo- and radio-
therapy, as well as worse survival rate. Although its expression is usually confined to 
G2-phase and mitosis, survivin is in cancer often expressed throughout the cell cycle. 
At least 5 different splice variants of the survivin gene have been reported in hu-
mans so far (wild type, 2α, 2B, 3B and deltaEx3). All survivin protein isoforms arising 
from the splice variants share the same N-terminus region, but differ in the carboxyl 
end. The transcript expression levels of various survivin isoforms have been signifi-
cantly associated with clinico-pathologic characteristics in several cancers.
